Abstract
This work gives a brief overview of carrier materials currently used in pharmaceutical studies on the three-dimensional (3D) semi-solid extrusion (SSE) printing of medicines for pediatrics. The suitability of using these carrier materials in pediatric formulations, concerning safety and toxicity, was reviewed by consulting the ‘Safety & Toxicity of Excipients for Pediatrics’ (STEP) database and the Food and Drug Administration (FDA) regulations. In the second part of this work, carrier materials were tested on their ability to form a semi-solid mixture with lactose by dual asymmetric centrifugation (DAC) and printing by SSE. With the combination of theoretical and experimental studies, this work will guide research toward grounded decision-making when it comes to carrier material selection for pharmaceutical pediatric 3D SSE printing formulations.
Reference78 articles.
1. delMoral-Sanchez, J.M., Gonzalez-Alvarez, I., Gonzalez-Alvarez, M., Navarro-Ruiz, A., and Bermejo, M. (2020). Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019. Pharmaceutics, 12.
2. Kader, R., Liminga, G., Ljungman, G., and Paulsson, M. (2021). Manipulations of Oral Medications in Paediatric Neurology and Oncology Care at a Swedish University Hospital: Health Professionals’ Attitudes and Sources of Information. Pharmaceutics, 13.
3. 3D printing of drugs: Expanding the options for child-tailored pharmacotherapy;Willemsteijn;Arch. Dis. Child.,2021
4. 3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities;Hassanin;J. Pharm. Sci.,2020
5. 3D Printed “Starmix” Drug Loaded Dosage Forms for Paediatric Applications;Scoutaris;Pharm. Res.,2018
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献